Literature DB >> 638980

Adenocarcinoma of the stomach: review of 1,497 cases.

J B Dupont, J R Lee, G R Burton, I Cohn.   

Abstract

The records of 1,497 patients with histologically proven adenocarcinoma of the stomach were reviewed from Charity Hospital over the 25-year period, 1948 to 1973. The operability rate was 82% and the resectability rate was 48%. In this series gastric carcinoma predominated in males and Negroes. Necropsy studies indicate a similar frequency of involvement of various organs in patients not operated upon as well as those subjected to a prior operation, which suggests the need for some therapeutic endeavors aimed at a wider base than the primary organ. The five-year survival rate, 7.4 overall, varied from 2.0% after esophagogastrectomy to 22.1% after radical subtotal gastrectomy, and to 30.3% for those with localized disease. One hundred one patients survived five years or more, and 5.4% survived ten years or more after the diagnosis of gastric cancer. Radical subtotal gastrectomy gave the best results in this series, whether measured in terms of median survival, five-year survival, or operative mortality. Esophagogastrectomy and by-pass procedures had high mortality and low survival rates, and should be reserved for special conditions.

Entities:  

Mesh:

Year:  1978        PMID: 638980     DOI: 10.1002/1097-0142(197803)41:3<941::aid-cncr2820410323>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  53 in total

1.  HELICOBACTER PYLORI AND GASTRIC CANCER: IS THERE A LINK?

Authors:  A C Anand; M Anand; P S Reddy; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Adenocarcinoma of the stomach: a review of 35 years and 1,710 cases.

Authors:  J R Breaux; W Bringaze; C Chappuis; I Cohn
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

3.  Toxocariasis masquerading as liver and lung metastatic nodules in patents with gastrointestinal cancer: clinicopathologic study of five cases.

Authors:  Sanghui Park; Yun Soo Kim; Yu Jin Kim; Sun Young Kyung; Jeong-Woong Park; Sung Hwan Jeong; Sang Pyo Lee
Journal:  Dig Dis Sci       Date:  2011-08-11       Impact factor: 3.199

4.  Thoracic invasion in gastric carcinoma.

Authors:  E Antón
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

5.  Malignancy in the aged: two 'cures' of stomach cancer.

Authors:  C E Evans
Journal:  Can Fam Physician       Date:  1983-09       Impact factor: 3.275

Review 6.  Preoperative staging of gastric cancer as precondition for multimodal treatment.

Authors:  A Sendler; H J Dittler; H Feussner; H Nekarda; E Bollschweiler; U Fink; H Helmberger; H Höfler; J R Siewert
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

7.  Gastric cancer survival in Sweden. Lack of improvement in 19 years.

Authors:  G Lundegårdh; H O Adami; B Malker
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

Review 8.  Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.

Authors:  J A Ajani; P F Mansfield; D M Ota
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 9.  Adjuvant treatment of gastric cancer.

Authors:  J S Macdonald; S F Schnall
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

10.  Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience.

Authors:  Philippe G Aftimos; Elie A Nasr; Dolly I Nasr; Roger J Noun; Fady L Nasr; Marwan G Ghosn; Joelle A El Helou; Georges Y Chahine
Journal:  Radiat Oncol       Date:  2010-06-04       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.